Business Description
Genomics BioSci & Tech Co Ltd
ISIN : TW0004195003
Total Employee Number:
115Description
Genomics BioSci & Tech Co Ltd is a Taiwan based commercial genome sequencing company formed to develop medical genetic testing. The services of the company include Sanger sequence service, Synthesis Service and Genomic Service.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1.36 | |||||
Debt-to-EBITDA | 54.91 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 1.11 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14 | |||||
3-Year EBITDA Growth Rate | -42.7 | |||||
3-Year FCF Growth Rate | -9.3 | |||||
3-Year Book Growth Rate | -16.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.72 | |||||
9-Day RSI | 39 | |||||
14-Day RSI | 39.15 | |||||
3-1 Month Momentum % | -35.83 | |||||
6-1 Month Momentum % | -26.2 | |||||
12-1 Month Momentum % | -9.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.14 | |||||
Quick Ratio | 0.67 | |||||
Cash Ratio | 0.31 | |||||
Days Inventory | 166.27 | |||||
Days Sales Outstanding | 76.87 | |||||
Days Payable | 70.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.8 | |||||
Shareholder Yield % | -12.99 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 32.45 | |||||
Operating Margin % | -9.71 | |||||
Net Margin % | -7.33 | |||||
EBITDA Margin % | 1.58 | |||||
FCF Margin % | -19.07 | |||||
OCF Margin % | -11.91 | |||||
ROE % | -10.6 | |||||
ROA % | -3.95 | |||||
ROIC % | -6.46 | |||||
3-Year ROIIC % | -10.09 | |||||
ROC (Joel Greenblatt) % | -7.71 | |||||
ROCE % | -7.6 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.5 | |||||
PB Ratio | 2.35 | |||||
Price-to-Tangible-Book | 2.39 | |||||
EV-to-EBIT | -26.21 | |||||
EV-to-EBITDA | 152.45 | |||||
EV-to-Revenue | 2.42 | |||||
EV-to-FCF | -12.6 | |||||
Price-to-GF-Value | 0.44 | |||||
Price-to-Projected-FCF | 41.49 | |||||
Earnings Yield (Greenblatt) % | -3.81 | |||||
FCF Yield % | -11.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genomics BioSci & Tech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 738.401 | ||
| EPS (TTM) (NT$) | -0.749 | ||
| Beta | -0.0312 | ||
| 3-Year Sharpe Ratio | -0.37 | ||
| 3-Year Sortino Ratio | -0.43 | ||
| Volatility % | 52.64 | ||
| 14-Day RSI | 39.15 | ||
| 14-Day ATR (NT$) | 0.646657 | ||
| 20-Day SMA (NT$) | 16.0325 | ||
| 12-1 Month Momentum % | -9.11 | ||
| 52-Week Range (NT$) | 14.9 - 36.85 | ||
| Shares Outstanding (Mil) | 80 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genomics BioSci & Tech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genomics BioSci & Tech Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| 1.02:1 Stock Split | 2023-08-08 | 23.77 (+1.04%) | ||
| 1.02:1 Stock Split | 2022-08-26 | 19.48 (+0.49%) |
Show
Entries
Genomics BioSci & Tech Co Ltd Frequently Asked Questions
What is Genomics BioSci & Tech Co Ltd(TPE:4195)'s stock price today?
The current price of TPE:4195 is NT$15.35. The 52 week high of TPE:4195 is NT$36.85 and 52 week low is NT$14.90.
When is next earnings date of Genomics BioSci & Tech Co Ltd(TPE:4195)?
The next earnings date of Genomics BioSci & Tech Co Ltd(TPE:4195) is .
Does Genomics BioSci & Tech Co Ltd(TPE:4195) pay dividends? If so, how much?
Genomics BioSci & Tech Co Ltd(TPE:4195) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Genomics BioSci & Tech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers